In the last month, the Google theme, which encompasses companies involved in online marketing and advertising technology, has seen a remarkable average gain of 19.97%. This robust growth underscores the burgeoning power of digital marketing and the internet's expanding role in connecting consumers with retailers.
🌐Tickers in Industry - $HHS, $GRPN, $BIDU, $GOOG, $YNDX, $ICLK
Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA) - Annualized Return + 58%
Key Players in the Market
Notable companies
The segment's success can be attributed to leading companies like Alphabet (NASDAQ:GOOG), Baidu (NASDAQ:BIDU), Yandex NV (NASDAQ:YNDX), and Groupon (NASDAQ:GRPN). These entities have been pivotal in driving the industry forward.
Emerging Companies
Additionally, emerging companies such as iClick Interactive Asia Group Ltd, Harte-Hanks, Inc., and SRAX Inc are also making significant strides in the field.
Market Capitalization Insights
The average market capitalization in the Google theme is an impressive $295.9B, with Alphabet (GOOG) holding the highest valuation at a staggering $1.7T. This wide range of market caps, from as low as $5.5M to as high as $1.7T, showcases the diverse nature of companies within this theme.
Stock Performance Highlights
Price Growth
The average weekly price growth for these stocks stood at 5.95%, with a monthly growth rate of 19.97% and a quarterly increase of 21.05%. Notably, ICLK experienced the highest price growth at 25%, while GOOG faced the most significant decline at -2.59%.
Volume Trends
In terms of trading volume, the average weekly volume growth was -0.94%, with a monthly decrease of -4.86% and a quarterly growth of 2.14%.
Market Cap Fluctuations
Fundamental Analysis Ratings
While the article does not delve into specific ratings, it's clear that the Google industry is undergoing a significant transformation, driven by the digital shift in advertising and marketing strategies.
This analysis of the Google industry stocks reveals a sector in robust health, buoyed by technological advancements and a digital-first approach in marketing and advertising. The growth and dynamism of this industry present an optimistic outlook for the future.
HHS : HHS has shown a promising upward trend, surpassing its 50-day Moving Average on October 30, 2023, signaling a shift from a bearish to a bullish trajectory. Historical data reveals that in all 15 comparable past occurrences, the stock price continued to climb in the subsequent month. This robust track record suggests a 90% likelihood of the current upward trend persisting. Investors may find this trend change a compelling opportunity for potential gains.
GRPN : On November 13, 2023, GRPN's RSI Indicator made a noteworthy move, exiting the oversold territory. This shift may indicate a transition from a bearish to a bullish trend, prompting traders to consider buying the stock or call options. Notably, our A.I. analysis reviewed 30 similar instances where the indicator left oversold conditions, and in an impressive 87% of those cases, the stock experienced upward momentum. These statistics suggest a high probability of a positive price movement ahead, making GRPN an enticing prospect for traders seeking potential gains.
BIDU : On November 28, 2023, BIDU's 10-day RSI Indicator made a notable move, exiting the overbought zone. This shift may indicate a potential shift from a bullish to a bearish trend, prompting traders to consider selling the stock or exploring put options. Notably, our analysis, utilizing Tickeron's A.I.dvisor, examined 28 instances where the RSI Indicator left the overbought territory, and in a substantial 82% of those cases, the stock exhibited a downward trajectory in the subsequent days. These statistics suggest a considerable likelihood of a price decline in the near term, warranting caution for investors in BIDU.
HHS moved above its 50-day moving average on May 16, 2024 date and that indicates a change from a downward trend to an upward trend. In of 16 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 15, 2024. You may want to consider a long position or call options on HHS as a result. In of 62 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HHS just turned positive on April 22, 2024. Looking at past instances where HHS's MACD turned positive, the stock continued to rise in of 30 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HHS advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HHS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HHS broke above its upper Bollinger Band on May 15, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HHS entered a downward trend on May 15, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.573) is normal, around the industry mean (2.373). P/E Ratio (2.381) is within average values for comparable stocks, (20.329). Projected Growth (PEG Ratio) (0.590) is also within normal values, averaging (1.527). Dividend Yield (0.000) settles around the average of (0.126) among similar stocks. P/S Ratio (0.280) is also within normal values, averaging (150.298).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of marketing and shopper advertising services
Industry MetalFabrication